Research Tree new note out2 Apr 2024 08:40
https://*********************/companies/uk/asset-management/tern-plc/research/progressive-equity-research/progressive-tern-core-portfolio-thriving/30_a93eee41-1d2e-42cd-a8b9-dba326926da6/94adaace-1450-48fc-95c7-a630aafaa93d
‘the group has been able to reduce costs by an estimated 40% under the new structure. the new management team structure is focused on delivering ‘material’ value from its current portfolio companies before considering any new investments. ’
‘there has been a flood of capital to the generative ai space, and research by cb insights highlights some generative ai start-ups have been achieving valuations more than 100x their forward-looking revenue, with generative ai companies averaging around 50x.’
‘device authority’s modularised licence platform ksaas (keyscaler software as a service) is built on microsoft’s azure cloud and was awarded rising azure technology 2023 microsoft partner of the year. device authority has a strong presence in the uk, with a ‘go to market’ in the us and further offices in bangalore.’
“talking medicines’ recent fundraise will provide capital for the next stage of development and continued expansion in the us. talking medicines is well established in a category of ai that is achieving 50x revenue multiples on average’
‘(wyld) customer acquisition is expected to accelerate in 2024, with a ramp-up in revenue following testing and manufacturing of wyld’s satellite iot products (which was a big q4 focus).’
‘all four businesses are on a positive trajectory, with significant momentum. we see huge potential in the next phase of growth as portfolio companies work with investment partners to achieve additional recognition and scale. ‘